Patient’s Corner: Living with Chronic Illness Vol. 3

By Dorothy Leone-Glasser

Breast cancer survivors face many challenges while going through treatment and in post treatment.  They experience a wide range of physical, mental, emotional and spiritual pain. There are lingering side effects to treatment that are long term and can be hard to manage. Many times, the fear of what will happen is overwhelming.  Cancer survivors live with fearing a recurrence, especially with Stage 4 Cancer. This is especially real for women of color, since they have the highest recurrence rates and the highest mortality rates.  

I met Tiah at an Rx in Reach GA Coalition Capitol Day. Being a survivor of Cancer myself, we knew women we would have a special bond. When we look at the journey of a woman living and thriving beyond cancer, oftentimes they don’t get a chance to take a break from the day-to-day challenges of life.  These women are mothers, daughters, sisters and aunties, caregivers and pillars of their families. They are leaders in their community and on their jobs and so much more. One of the biggest needs is how to manage or cope with their daily life challenges while healing from the devastation of cancer and the damaging toll of treatment. Patients seldom receive the information and counseling on how to re-enter life. Cancer survivors and their families and friends need the education, resources and guidance from a healthcare team that supports the health of their mind and body.

Here are some ‘Tips’ from Tiah:

  • SEE ME AS A PERSON BEFORE SEEING ME AS A PATIENT. We are more than our disease.  We have families, friends, jobs, hobbies, goals and dreams.  When you are treating me as a patient, remember – I am not a “one size fits all”. I am uniquely me!  Take time to learn a little bit more about me and what could potentially be barriers to my care.   
  • BE PATIENT WITH ME. What you see on the outside is not always a reflection of what’s going on the inside.  As a patient, I may not always verbalize how I truly feel or the problems I face.  Many patients don’t want to be seen as a burden so we just keep our superhero capes on and press our way through.
  • CANCER IS COMPLICATED. SOMETIMES WE AREN’T GIVEN THE PROPER DIAGNOSIS OR ARE MISDIAGNOSED. Because I look healthy or are very young doesn’t mean I am not seriously ill. I know when something is wrong with my body. I need a care team that hears me.  
  • SOME DAYS I JUST DON’T HAVE THE STRENGTH TO ADVOCATE FOR MYSELF.   This is why having a caregiver/advoacte is so important. 
  • LIVING WITH A CHRONIC ILLNESS CAN BE VERY EMOTIONAL . Cancer comes with the challenges of side effects of treatments and drugs, isolation, fear and anxiety of disease progression or recurrence; all causing a rough ride on an emotional rollercoaster.
Tiah Tomlin headshot
Tiah Tomlin
Founder & CEO,
My Style Matters

Dorothy Leone Glasser headshotDorothy Leon Glasser
Executive Director, Advocates for Responsible Care
Co-Chair, Georgia Bio Patient Advocacy Alliance
By Maria Thacker Goethe October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape
October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.
October 1, 2025
September 30, 2025 WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, Americans have subsidized the research and development necessary to bring newer and better medicines to patients around the world. As we saw with defense spending and NATO, the solution is not to weaken a strategically important American industry, but for other countries to pay their fair share. “Today’s announcement in the Oval Office highlights the problems with a drug delivery system where half of the cost of innovative medicines goes to middlemen and distributors, and where the supply chain distorts prices paid by the American people. We support a new framework that addresses the cost of medicines by simplifying the system - and making medicines directly available to patients. “But importing socialist price controls through most-favored nation policies fundamentally does not address the imbalance in international pricing for innovative medicines. MFN will not lower the out-of-pocket prices that most Americans pay for medicines. Even worse, it will jeopardize the entrepreneurial spirit and deter the capital necessary for a vibrant and essential American biotechnology industry to thrive and may cause most harm to small and midsize biotech companies, which are responsible for discovering more than half of all new treatments. “Without these biotech innovators and a free-market system, we risk slower scientific progress, decreased access to new medicines, compromised national security, fewer American jobs and perhaps most tragically, a diminished hope for those suffering with illness and disease. There are much better ways to address this problem than MFN.” ###
MORE POSTS